Posted on February 26th, 2013 by Logan Lafferty
When it comes to making inroads in the fight against cancer, two heads are better than one…Mayo Clinic molecular biologist Jim Maher, Ph.D., and University of Minnesota medicinal chemist Gunda Georg, Ph.D., led the research, which is published the findings in the journal PLoS ONE…The findings suggest that drugs might work by blocking the yeast cells' sugar digestion, essentially starving them. The researchers think that the same approach might one day be used to treat patients with the two rare cancers, and they are planning studies to pursue that idea.
Additional Coverage: HealthNewsDigest,
You must be logged-in to the site to post a comment.